FGF23 and hydrops fetalis: Fibroblast growth factor-23 (FGF-23), a hormone involved in phosphorus metabolism that increases progressively as kidney function declines, was significantly associated with mortality, atherosclerotic events, heart failure (HF), and ESKD in CKD patients [52,53].